Claudin1 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells by upregulating the expression and nuclear entry of β‑catenin
Authors:
Open Access
- 20 August 2018
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 16 (4) , 3445-3451
Abstract
The aim of the present study was to measure the expression of Claudin (CLDN) 1 in nasopharyngeal carcinoma (NPC) and to determine its biological function and mechanism of action. Reverse transcription‑quantitative polymerase chain reaction and western blotting were performed to measure the expression of CLDN1 mRNA and protein, respectively, in the immortalized human nasopharyngeal epithelial cell line NP69 and NPC‑TW01 cells. Subsequently, small interfering RNA against CLDN1 and the LV‑GFP‑PURO‑CLDN1 lentivirus were transfected into NPC‑TW01 cells. Western blotting was used to determine the effects of CLDN1 down‑ and upregulation on the expression of the epithelial mesenchymal transition (EMT) markers E‑cadherin and vimentin. In addition, the effect of CLDN1 on the expression of β‑Catenin was determined. The results demonstrated that levels of CLDN1 mRNA and protein in NPC cells were significantly higher than in NP69 cells. Furthermore, the downregulation of CLDN1 inhibited the proliferation, invasion and migration of NPC‑TW01 cells. The results of western blotting demonstrated that the downregulation of CLDN1 resulted in the upregulation of E‑cadherin and inhibition of vimentin in NPC‑TW01 cells. By contrast, the overexpression of CLDN1 resulted in the downregulation of E‑cadherin and upregulation of vimentin in NPC‑TW01 cells. The downregulation of β‑catenin attenuated the cancer‑promoting effect of CLDN1 on NPC‑TW01 cells, whereas the upregulation of β‑catenin reversed the tumor‑suppressing effect of CLDN1 downregulation on NPC‑TW01 cells. The results of the present study therefore demonstrate that CLDN1 expression is elevated in NPC cells. As an oncogene, CLDN1 promotes the proliferation, invasion and migration of NPC cells by upregulating the expression and nuclear entry of β‑catenin.Keywords
This publication has 40 references indexed in Scilit:
- Claudin-1 as a Biomarker of Cervical Cytology and HistologyPathology and Oncology Research, 2015
- Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesotheliomaAnnals of Diagnostic Pathology, 2015
- Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulationJournal of Biological Chemistry, 2013
- RETRACTED ARTICLE: Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cellsOncogene, 2012
- Down-Regulation of Claudin-3 Is Associated with Proliferative Potential in Early Gastric CancersDigestive Diseases and Sciences, 2012
- Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinomaLaboratory Investigation, 2011
- Expression of CLDN1 in colorectal cancer: A novel marker for prognosisInternational Journal of Oncology, 2011
- Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinomaHuman Pathology, 2010
- Claudin immunolocalization in neonatal mouse epithelial tissuesCell and tissue research, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001